Loyola University Chicago is a clinical research site located in Maywood, Illinois, United States 60153.
Crixeo Health Trust Score: 85/100 (GOOD). This profile has not yet been claimed by the site owner.
Loyola University Chicago has participated in 40 clinical trials with 10 currently active.
Therapeutic areas: Non-Hodgkin's Lymphoma, Pulmonary Embolism, Covid-19.
Sponsors: Spectrum Pharmaceuticals, Inc, Thrombolex, Inc., Ohio State University Comprehensive Cancer Center.
Trust Score: 85/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Loyola University Chicago has a Crixeo Trust Score of 85/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Loyola University Chicago has 40 clinical trials on record, with 10 currently active. Their work covers Non-Hodgkin's Lymphoma, Pulmonary Embolism, Covid-19.
Loyola University Chicago has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.